Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2008
10/30/2008US20080268064 fractioning blood to produce a blood component, shaping the cartilage defect to expose subchondral bone, microfracturing the subchondral bone, and applying the blood component to the microfractured subchondral bone
10/30/2008US20080268063 Coated Controlled Release Polymer Particles as Efficient Oral Delivery Vehicles for Biopharmaceuticals
10/30/2008US20080268061 injection solutions containing the nanoparticles as well as to the use thereof for the treatment of cancer; release of the therapeutically active substances is caused, initiated or substantially enhanced by an alternating magnetic field
10/30/2008US20080268051 Anti-angiogenesis; viscosity inducing component is injectable into the vitreous of a mammalian eye without permanently diminishing visual acuity
10/30/2008US20080268047 supplying a plurality of solutions with syringe pumps for fluid bed coating, coating a substrate with a pH dependent soluble polymer solution, coating the polymer coated substrate with layer of a solution of a therapeutically active substance and layer of a second polymer solution and alternating
10/30/2008US20080268032 Stabilizing Alkylglycoside Compositions and Methods Thereof
10/30/2008US20080268031 Therapeutic Treatment of Dermatologic Skin Disorders
10/30/2008US20080268030 Gene therapy for diabetic ischemic disease
10/30/2008US20080268029 Peptide fragment with immunogenic or therapeutic properties against ischemic cardiovascular diseases
10/30/2008US20080268015 Methods and compositions for promoting localization of pharmaceutically active agents to bone
10/30/2008US20080268012 Extracted demineralized bone matrix having osteoinductive activity
10/30/2008US20080268007 Beauty/medication patch
10/30/2008US20080267990 Nucleotide sequences coding interferon inducer for use in detection of mycobacterial infection
10/30/2008US20080267989 Self aggregating monomeric fusion protein for use in induction of immune response to human immunodeficiency viral infection
10/30/2008US20080267987 Major histocompatibility complex polypeptide for use in targeting, detecting and purifying antigen-specific T-cells; for treatment and prevention of inflammatory, arthritic and autoimmune disease
10/30/2008US20080267980 Complement Receptor 2 Targeted Complement Modulators
10/30/2008US20080267977 Combined immunological agent and sensitizing agent for the treatment of cancer
10/30/2008US20080267975 Using lymphocyte profiles comprising aberrant transmembrane receptor tyrosine kinase (Mer) expression as evaluative tool in screening for blood clotting and/or cell proliferative disorders
10/30/2008US20080267969 Treatment of Pulmonary Hypertension Using an Agent That Inhibits a Tissue Factor Pathway
10/30/2008US20080267967 Modulation of cd200 receptors
10/30/2008US20080267966 Polypeptides from Non-Typeable Haemophilus Influenzae
10/30/2008US20080267965 Use of Bcma as an Immunoregulatory Agent
10/30/2008US20080267962 Albumin Fusion Proteins
10/30/2008US20080267961 SOLUBLE ErbB3 AND TREATMENT OF CANCER
10/30/2008US20080267956 Growth factor antagonists for organ transplant alloimmunity and arteriosclerosis
10/30/2008US20080267950 Molecular determinants of myeloma bone disease and uses thereof
10/30/2008US20080267949 Peptides capable of binding to serum proteins
10/30/2008US20080267945 Salts of Isophosphoramide Mustard and Analogs Thereof as Anti-Tumor Agents
10/30/2008US20080267944 Expression vector comprising nucleotide sequences coding serine potease like protein for use in depleting fibrinogen from blood and diagnosing dysprothrombinemias
10/30/2008US20080267943 Innate Immune Receptor Directed Biocides
10/30/2008US20080267942 7-hydroxy-6-{[1-methyl-3-(1,3-thiazol-5-yl)propyl]amino}-4,5,6,7-tetrahydroimidazo[4,5,1-jk][1]benzazepin-2(1H)-one; agonists at the beta-2 adrenoceptor; feed additives for livestock animals; improving meat yield or meat quality
10/30/2008US20080267941 Nutrition Comprising Betaine Against Muscle Wasting
10/30/2008US20080267940 Using protamine to precipitate fibrinogen from whole blood; wound healing agent
10/30/2008US20080267936 Treatment of trauma-hemorrhage with short oligopeptides
10/30/2008US20080267929 Use of stem cells to generate inner ear cells
10/30/2008US20080267924 Repairing tissue and reducing localized fluid retention after surgery via exposure to vascular endothelial growth factors before, during and after surgery; tissue repair
10/30/2008US20080267918 Serine protease inhibitors; replication inhibition
10/30/2008US20080267917 N-functionalized amides as hepatitis c serine protease inhibitors
10/30/2008US20080267916 Cyclic p3 tripeptide hepatitis c serine protease inhibitors
10/30/2008US20080267915 Hcv Ns3-Ns4a Protease Inhibition
10/30/2008US20080267914 Chemical Compounds
10/30/2008US20080267913 Method to enhance hematopoiesis
10/30/2008US20080267912 Novel inhibitors of glutaminyl cyclase
10/30/2008US20080267911 Imidazole derivatives; Alzheimer's Disease, Down syndrome and Huntington's Disease; hypotensive agents; sleeping and eating disorders, anxiolytic agents, antidepressants, antiepileptic agents; drug abuse/withdrawl; 1-(3,4-dimethoxyphenyl)-3-(3-(5-methyl-1H-imidazol-1-yl)propyl)thiourea
10/30/2008US20080267910 Nucleotide sequences coding interleukin-21/22 for use in identifying modulators for prevention and treatment of viral infection and cell proliferative disorders
10/30/2008US20080267909 Using acetyl-low density lipoprotein (acetyl-LDL) and an acyl-coenzyme A:cholesterol acyltransferase (ACAT) inhibitor as stimulatory tools in identifying modulators which treat and/prevent heart, cardiovascular and diabetic disorders
10/30/2008US20080267908 Using alteration in interleukin-32 binding to proteinase-3 to identify compounds which maybe useful in treatment of inflammatory disorders
10/30/2008US20080267907 Therapeutic mixture comprising insulin, ethylenediamine and an antimicrobial preservative; improved chemical and storage stability
10/30/2008US20080267906 Novel Spirotropane Compounds and Methods for the Modulation of Chemokine Receptor Activity
10/30/2008US20080267905 Antiinflammatory; angiogenesis inhibitors; synergistic; kits
10/30/2008US20080267902 Blood products with binding agent
10/30/2008US20080267881 Peptide-based compounds for use as targeting vectors that bind to receptors associated with angiogenesis; may thus be used for diagnosis or therapy of, for example, malignant diseases, heart diseases, endometriosis, inflammation-related diseases, rheumatoid arthritis and Kaposi's s sarcoma
10/30/2008US20080267877 Administering carrier molecule such as albumin conjugated to mannose-6-phosphate; particularly targeting Hepatic Stellate Cells (HSC); glomeruloscherosis, interstitial fibrosis, lung fibrosis, atherosclerosis, Crohn's disease, colitis ulcerosa, glomerulonephritis and sepsis; diagnosis
10/30/2008US20080267875 Androgens conjugated with mammalian proteins; diagnosis or treatment of solid cancer and hematological malignancies; exhibit synergistic action together with a cytoskeleton-acting drug; prostate cancer
10/30/2008US20080267872 The 98P4B6 gene, its fragment, its encoded protein, variants , or a fragment, can be used to elicit a humoral or cellular immune response; antibodies or T cells reactive with 98P4B6 can be used in active or passive immunization
10/30/2008US20080267871 Cardioinhibitory/ Antihypertensive Novel Endogenous Physiologically Active Peptide
10/30/2008US20080264416 Method of Treating Diabetes Mellitus in a Patient
10/30/2008DE102007020152A1 Mittel zur antiinfektiven Behandlung eines Patienten Anti-infective agent for treatment of a patient
10/30/2008CA2720269A1 Composition for enhancing bone formation
10/30/2008CA2690772A1 Novel peptide amphiphiles having improved solubility and methods of using same
10/30/2008CA2685005A1 Glycated milk and uses thereof
10/30/2008CA2684834A1 Demannosylated recombinant factor viii for the treatment of patients with haemophilia a
10/30/2008CA2684750A1 Stable recombinant adenosine deaminase
10/30/2008CA2684749A1 Enzymatic anticancer therapy
10/30/2008CA2684707A1 Mo-1, a gene associated with morbid obesity
10/30/2008CA2684453A1 Medicaments and methods to treat autoimmune disease and cancer
10/30/2008CA2684330A1 Optimized nucleotide sequences of vb6-845 for expression of recombinant proteins
10/30/2008CA2684328A1 Endotoxin removal
10/30/2008CA2683015A1 Wound healing compositions containing keratin biomaterials
10/30/2008CA2682127A1 Pulmonary delivery of spherical insulin microparticles
10/30/2008CA2678190A1 Novel viii factors for the treatment of type a hemophilia
10/30/2008CA2677399A1 Macrocyclic ghrelin receptor modulators and methods of using the same
10/29/2008EP1986011A2 Peptide epitopes recognized by disease promoting CD4+ T lymphocytes
10/29/2008EP1985706A2 Di- or oligomer of a dimer, trimer, quatromer or pentamer of recombinant fusion proteins
10/29/2008EP1985703A2 Peripheral nervous system specific sodium channels, DNA encoding therefor, crystallization, X-ray diffraction, computer molecular modeling, rational drug design, drug screening, and methods of making and using thereof
10/29/2008EP1985697A1 Modified phosphatases
10/29/2008EP1985632A2 Use of VEGF2 antibodies for inhibiting photoreceptor cell proliferation
10/29/2008EP1985631A1 Demannosylated recombinant factor VIII for the treatment of patients with hemophiila A
10/29/2008EP1985629A1 Pro-apoptotic molecules and therapeutic uses thereof
10/29/2008EP1985628A1 Bis-met histones
10/29/2008EP1985626A1 P. gingivalis antigenic composition
10/29/2008EP1985625A2 Synthetic peptide constructs for the diagnosis and treatment of periodontitus associated with porphyromonas gingivalis
10/29/2008EP1985308A2 Water-soluble compositions of bioactive lipophilic compounds
10/29/2008EP1985304A2 Novel compounds and their effects on feeding behaviour
10/29/2008EP1985303A1 Oral composition containing interferon-
10/29/2008EP1985302A1 Medicament for treatment of tumor and the use thereof
10/29/2008EP1985301A1 Method of inducing cytotoxic t-cell, cytotoxic t-cell inducer and, produced therewith, pharmaceutical composition and vaccine
10/29/2008EP1985276A1 Treatment of movement disorders by a combined use of a chemodenervating agent and automated movement therapy
10/29/2008EP1984546A1 Vasopressin pathway polymorphisms as indicators of subject outcome in critically ill subjects
10/29/2008EP1984522A2 Methods of increasing lymphatic function
10/29/2008EP1984503A1 Modified coagulation factor vila with extended half-life
10/29/2008EP1984397A2 Vegf variants
10/29/2008EP1984387A1 New polypeptides kxk and their use
10/29/2008EP1984040A1 Drug-eluting intravascular prostheses and methods of use
10/29/2008EP1984020A2 Means and methods for modulating stem cell mobilization
10/29/2008EP1984019A1 Novel phosphopeptides and uses thereof in preventing kidney stone formation
10/29/2008EP1984018A2 Intraventricular enzyme delivery for lysosomal storage diseases
10/29/2008EP1984017A2 Methods of treating or preventing tissue damage caused by increased blood flow
10/29/2008EP1984016A1 Use of insulin-like factor 3 for treating osteoporosis and bone disorders
10/29/2008EP1984015A2 Methods and compositions for treating asthma in human and non human primates
1 ... 878 879 880 881 882 883 884 885 886 887 888 889 890 891 892 893 894 895 896 897 898 ... 3163